Cardiff Oncology, Inc.
Hedge Funds Holdings
Last updated:
Cardiff Oncology, Inc.‘s stocks are currently a part of 35 hedge funds’ portfolios, which represents 6.76% of the total amount of its stocks outstanding. This makes up a total of 2.94M shares of Cardiff Oncology, Inc.. Compared to the previous quarter, the number fell by -61.74% or -4.75M shares fewer. As for the holding position changes, 25.71% (9) of current hedge fund investors increased the number of shares held, 8.57% (3) of current holders sold a part of the shares held, and 14.29% (5) closed the holdings completely. 5 hedge funds are new holders of Cardiff Oncology, Inc. stock in Q1 2023, it is 14.29% of total holders.
Hedge funds holding Cardiff Oncology (Q2 2020 – Q1 2023)
| Q2 2020 | 22 |
|---|---|
| Q3 2020 | 63 |
| Q4 2020 | 79 |
| Q1 2021 | 69 |
| Q2 2021 | 85 |
| Q3 2021 | 86 |
| Q4 2021 | 83 |
| Q1 2022 | 82 |
| Q2 2022 | 57 |
| Q3 2022 | 49 |
| Q4 2022 | 57 |
| Q1 2023 | 35 |
Hedge funds changes in Cardiff Oncology positions (Q2 2020 – Q1 2023)
| Q2 2020 | 22 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2020 | 45 | 10 | 6 | 4 | -2 |
| Q4 2020 | 36 | 16 | 20 | 19 | -12 |
| Q1 2021 | 18 | 32 | 13 | 28 | -22 |
| Q2 2021 | 31 | 23 | 24 | 15 | -8 |
| Q3 2021 | 16 | 30 | 26 | 15 | -1 |
| Q4 2021 | 13 | 25 | 26 | 16 | 3 |
| Q1 2022 | 17 | 19 | 34 | 18 | -6 |
| Q2 2022 | 9 | 14 | 23 | 32 | -21 |
| Q3 2022 | 5 | 13 | 15 | 13 | 3 |
| Q4 2022 | 17 | 10 | 14 | 8 | 8 |
| Q1 2023 | 5 | 9 | 3 | 5 | 13 |
Hedge funds changes in Cardiff Oncology stock options (Q2 2020 – Q1 2023)
| Q2 2020 | 0 | 0 |
|---|---|---|
| Q3 2020 | 8,465,000 | 8,849,000 |
| Q4 2020 | 14,088,000 | 19,492,000 |
| Q1 2021 | 3,687,000 | 8,465,000 |
| Q2 2021 | 2,111,000 | 2,350,000 |
| Q3 2021 | 2,883,000 | 2,582,000 |
| Q4 2021 | 895,000 | 1,360,000 |
| Q1 2022 | 348,000 | 468,000 |
| Q2 2022 | 445,000 | 385,000 |
| Q3 2022 | 302,000 | 255,000 |
| Q4 2022 | 5,060 | 75,440 |
| Q1 2023 | 9,097,000 | 132,829,000 |